Peripheral immune cells in NAFLD patients: A spyhole to disease progression
Summary: Nonalcoholic fatty liver disease (NAFLD) is a worldwide leading cause of chronic liver disease, but we still lack ideal non-invasive tools for diagnosis and evaluation of nonalcoholic steatohepatitis (NASH) and related liver fibrosis in NAFLD population. Systemic immune dysregulations such...
| 出版年: | EBioMedicine |
|---|---|
| 主要な著者: | Shuang-Zhe Lin, Jian-Gao Fan |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Elsevier
2022-01-01
|
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2352396421005624 |
類似資料
The role of the microbiome in NAFLD and NASH
著者:: Aleksandra A Kolodziejczyk, 等
出版事項: (2018-12-01)
著者:: Aleksandra A Kolodziejczyk, 等
出版事項: (2018-12-01)
Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
著者:: Ankoor H. Patel, 等
出版事項: (2024-07-01)
著者:: Ankoor H. Patel, 等
出版事項: (2024-07-01)
An Update on the Chemokine System in the Development of NAFLD
著者:: Naoto Nagata, 等
出版事項: (2022-06-01)
著者:: Naoto Nagata, 等
出版事項: (2022-06-01)
Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content
著者:: Haoxiang Zhu, 等
出版事項: (2025-01-01)
著者:: Haoxiang Zhu, 等
出版事項: (2025-01-01)
Noninvasive Diagnosis of NAFLD and NASH
著者:: Valeria Annarita Piazzolla, 等
出版事項: (2020-04-01)
著者:: Valeria Annarita Piazzolla, 等
出版事項: (2020-04-01)
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic1[S]
著者:: D.Lee Gorden, 等
出版事項: (2015-03-01)
著者:: D.Lee Gorden, 等
出版事項: (2015-03-01)
An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients
著者:: Pathik Parikh, 等
出版事項: (2016-01-01)
著者:: Pathik Parikh, 等
出版事項: (2016-01-01)
Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery
著者:: Marielle Malucelli, 等
出版事項: (2023-11-01)
著者:: Marielle Malucelli, 等
出版事項: (2023-11-01)
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
著者:: Wasitha P. D. W. Thilakarathna, 等
出版事項: (2024-02-01)
著者:: Wasitha P. D. W. Thilakarathna, 等
出版事項: (2024-02-01)
Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
著者:: Man Wang, 等
出版事項: (2022-10-01)
著者:: Man Wang, 等
出版事項: (2022-10-01)
The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
著者:: Lucia Carulli, 等
出版事項: (2019-02-01)
著者:: Lucia Carulli, 等
出版事項: (2019-02-01)
Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
著者:: I. M. Iljinsky, 等
出版事項: (2019-10-01)
著者:: I. M. Iljinsky, 等
出版事項: (2019-10-01)
Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways
著者:: Glenn S. Gerhard, 等
出版事項: (2018-07-01)
著者:: Glenn S. Gerhard, 等
出版事項: (2018-07-01)
Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD)
著者:: Naveen Kalra, 等
出版事項: (2009-01-01)
著者:: Naveen Kalra, 等
出版事項: (2009-01-01)
Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
著者:: Apollinariya V. Bogolyubova, 等
出版事項: (2017-12-01)
著者:: Apollinariya V. Bogolyubova, 等
出版事項: (2017-12-01)
Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact
著者:: David Højland Ipsen, 等
出版事項: (2021-01-01)
著者:: David Højland Ipsen, 等
出版事項: (2021-01-01)
Nonalcoholic fatty liver disease: The role of quercetin and its therapeutic implications
著者:: Maria Sotiropoulou, 等
出版事項: (2021-01-01)
著者:: Maria Sotiropoulou, 等
出版事項: (2021-01-01)
Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
著者:: Mahsa Khodadoostan, 等
出版事項: (2016-01-01)
著者:: Mahsa Khodadoostan, 等
出版事項: (2016-01-01)
The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)
著者:: Amanda Hanson, 等
出版事項: (2018-08-01)
著者:: Amanda Hanson, 等
出版事項: (2018-08-01)
TREM2 Regulates the Removal of Apoptotic Cells and Inflammatory Processes during the Progression of NAFLD
著者:: Imke Liebold, 等
出版事項: (2023-01-01)
著者:: Imke Liebold, 等
出版事項: (2023-01-01)
Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study
著者:: Yu Zhang, 等
出版事項: (2020-06-01)
著者:: Yu Zhang, 等
出版事項: (2020-06-01)
Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
著者:: Panagiotis Theofilis, 等
出版事項: (2022-05-01)
著者:: Panagiotis Theofilis, 等
出版事項: (2022-05-01)
Nonalcoholic fatty liver disease
著者:: Lafaine M. Grant, 等
出版事項: (2004-07-01)
著者:: Lafaine M. Grant, 等
出版事項: (2004-07-01)
Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis
著者:: Mohamed Salaheldin, 等
出版事項: (2023-08-01)
著者:: Mohamed Salaheldin, 等
出版事項: (2023-08-01)
Male LEW.1WR1 Rats Develop Metabolic Dysfunction, Steatohepatitis, and Liver Damage
著者:: Quiana C. Wilkerson-Vidal, 等
出版事項: (2024-04-01)
著者:: Quiana C. Wilkerson-Vidal, 等
出版事項: (2024-04-01)
Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy
著者:: Reeju Amatya, 等
出版事項: (2023-07-01)
著者:: Reeju Amatya, 等
出版事項: (2023-07-01)
ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
著者:: A. V. Polukhina, 等
出版事項: (2017-11-01)
著者:: A. V. Polukhina, 等
出版事項: (2017-11-01)
The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
著者:: Ji-Young Cha, 等
出版事項: (2018-12-01)
著者:: Ji-Young Cha, 等
出版事項: (2018-12-01)
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
著者:: Margaret LP Teng, 等
出版事項: (2023-04-01)
著者:: Margaret LP Teng, 等
出版事項: (2023-04-01)
Association of vitamin D supplementation with serum leptin and metabolic parameters in Egyptian patients with non-alcoholic steatohepatitis: a prospective study
著者:: Hany Haroun Kaisar, 等
出版事項: (2020-08-01)
著者:: Hany Haroun Kaisar, 等
出版事項: (2020-08-01)
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
著者:: Umair Iqbal, 等
出版事項: (2019-03-01)
著者:: Umair Iqbal, 等
出版事項: (2019-03-01)
Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in Obese Chinese
著者:: Jiarui Chen, 等
出版事項: (2024-12-01)
著者:: Jiarui Chen, 等
出版事項: (2024-12-01)
Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
著者:: Li Rong, 等
出版事項: (2023-01-01)
著者:: Li Rong, 等
出版事項: (2023-01-01)
Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
著者:: Jennifer Gallacher, 等
出版事項: (2018-06-01)
著者:: Jennifer Gallacher, 等
出版事項: (2018-06-01)
Deciphering the role of aberrant DNA methylation in NAFLD and NASH
著者:: Meenakshi Vachher, 等
出版事項: (2022-10-01)
著者:: Meenakshi Vachher, 等
出版事項: (2022-10-01)
Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
著者:: Bing Yang, 等
出版事項: (2023-09-01)
著者:: Bing Yang, 等
出版事項: (2023-09-01)
Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
著者:: Bing Yang, 等
出版事項: (2022-09-01)
著者:: Bing Yang, 等
出版事項: (2022-09-01)
Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
著者:: Yoshihisa Takahashi, 等
出版事項: (2023-01-01)
著者:: Yoshihisa Takahashi, 等
出版事項: (2023-01-01)
Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients
著者:: Adrian T. Billeter, 等
出版事項: (2021-08-01)
著者:: Adrian T. Billeter, 等
出版事項: (2021-08-01)
Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations
著者:: CM Oneta
出版事項: (2002-09-01)
著者:: CM Oneta
出版事項: (2002-09-01)
類似資料
-
The role of the microbiome in NAFLD and NASH
著者:: Aleksandra A Kolodziejczyk, 等
出版事項: (2018-12-01) -
Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
著者:: Ankoor H. Patel, 等
出版事項: (2024-07-01) -
An Update on the Chemokine System in the Development of NAFLD
著者:: Naoto Nagata, 等
出版事項: (2022-06-01) -
Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content
著者:: Haoxiang Zhu, 等
出版事項: (2025-01-01) -
Noninvasive Diagnosis of NAFLD and NASH
著者:: Valeria Annarita Piazzolla, 等
出版事項: (2020-04-01)
